| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 39 | 2024 | 502 | 7.370 |
Why?
|
| Colonic Polyps | 14 | 2020 | 70 | 4.030 |
Why?
|
| Adenoma | 16 | 2019 | 94 | 3.120 |
Why?
|
| Gastrointestinal Diseases | 5 | 2021 | 51 | 2.230 |
Why?
|
| DNA Methylation | 10 | 2020 | 393 | 2.160 |
Why?
|
| Crocus | 8 | 2024 | 21 | 1.850 |
Why?
|
| Colonic Neoplasms | 9 | 2021 | 223 | 1.690 |
Why?
|
| Microsatellite Instability | 11 | 2024 | 47 | 1.490 |
Why?
|
| Middle Aged | 54 | 2025 | 11790 | 1.340 |
Why?
|
| Colonoscopy | 13 | 2024 | 117 | 1.270 |
Why?
|
| Humans | 88 | 2025 | 42113 | 1.180 |
Why?
|
| Aged | 39 | 2025 | 7958 | 1.170 |
Why?
|
| Male | 61 | 2025 | 22745 | 1.120 |
Why?
|
| Retrospective Studies | 17 | 2025 | 2466 | 1.030 |
Why?
|
| Female | 59 | 2025 | 23980 | 1.020 |
Why?
|
| Health Status Disparities | 4 | 2021 | 702 | 1.000 |
Why?
|
| Promoter Regions, Genetic | 7 | 2020 | 534 | 0.970 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2024 | 858 | 0.950 |
Why?
|
| Risk Factors | 20 | 2025 | 3933 | 0.890 |
Why?
|
| Hospitalization | 3 | 2023 | 477 | 0.890 |
Why?
|
| Carcinoma | 3 | 2015 | 106 | 0.890 |
Why?
|
| Diarrhea | 3 | 2022 | 95 | 0.870 |
Why?
|
| Ferritins | 2 | 2022 | 63 | 0.840 |
Why?
|
| Nutrigenomics | 1 | 2023 | 2 | 0.810 |
Why?
|
| Bacteria | 3 | 2021 | 285 | 0.790 |
Why?
|
| Mutation | 4 | 2019 | 1169 | 0.780 |
Why?
|
| Chromosome Aberrations | 2 | 2014 | 61 | 0.770 |
Why?
|
| Plant Extracts | 5 | 2024 | 303 | 0.730 |
Why?
|
| Hospital Mortality | 1 | 2023 | 205 | 0.720 |
Why?
|
| Dietary Supplements | 1 | 2023 | 208 | 0.710 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 13 | 0.690 |
Why?
|
| Enzymes | 1 | 2021 | 34 | 0.680 |
Why?
|
| Vomiting | 1 | 2021 | 14 | 0.680 |
Why?
|
| Nausea | 1 | 2021 | 13 | 0.680 |
Why?
|
| Lymph Nodes | 1 | 2021 | 73 | 0.680 |
Why?
|
| Abdominal Pain | 1 | 2021 | 25 | 0.670 |
Why?
|
| Condylomata Acuminata | 1 | 2020 | 6 | 0.670 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2020 | 187 | 0.670 |
Why?
|
| Prevalence | 12 | 2025 | 1593 | 0.670 |
Why?
|
| Human papillomavirus 16 | 1 | 2020 | 37 | 0.660 |
Why?
|
| Anus Neoplasms | 1 | 2020 | 43 | 0.640 |
Why?
|
| Adult | 31 | 2025 | 13437 | 0.640 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 164 | 0.640 |
Why?
|
| Uterine Diseases | 1 | 2019 | 5 | 0.630 |
Why?
|
| Polyps | 1 | 2019 | 9 | 0.630 |
Why?
|
| Carotenoids | 2 | 2020 | 74 | 0.620 |
Why?
|
| Colon | 3 | 2021 | 118 | 0.620 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2019 | 24 | 0.610 |
Why?
|
| Interleukin-10 | 1 | 2020 | 86 | 0.610 |
Why?
|
| Spices | 1 | 2019 | 9 | 0.600 |
Why?
|
| Adenomatous Polyps | 2 | 2016 | 12 | 0.600 |
Why?
|
| Anemia, Sickle Cell | 1 | 2021 | 185 | 0.600 |
Why?
|
| Precancerous Conditions | 3 | 2016 | 83 | 0.590 |
Why?
|
| Risk Assessment | 6 | 2021 | 844 | 0.580 |
Why?
|
| Deinococcus | 4 | 2006 | 5 | 0.580 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 508 | 0.560 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2015 | 255 | 0.560 |
Why?
|
| Liver | 1 | 2021 | 503 | 0.550 |
Why?
|
| Receptors, Calcitriol | 2 | 2024 | 69 | 0.540 |
Why?
|
| Membrane Glycoproteins | 1 | 2018 | 221 | 0.520 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 683 | 0.520 |
Why?
|
| Feces | 2 | 2016 | 126 | 0.510 |
Why?
|
| Neoplasms | 3 | 2022 | 1341 | 0.500 |
Why?
|
| Case-Control Studies | 7 | 2024 | 1265 | 0.500 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2024 | 101 | 0.500 |
Why?
|
| Helicobacter Infections | 2 | 2014 | 84 | 0.500 |
Why?
|
| Helicobacter pylori | 2 | 2014 | 116 | 0.490 |
Why?
|
| Colitis | 3 | 2021 | 69 | 0.480 |
Why?
|
| Smoking | 2 | 2020 | 1019 | 0.480 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 363 | 0.480 |
Why?
|
| Hospitals, University | 1 | 2015 | 39 | 0.480 |
Why?
|
| Receptor, EphA6 | 1 | 2015 | 2 | 0.460 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 744 | 0.460 |
Why?
|
| Prognosis | 5 | 2022 | 847 | 0.460 |
Why?
|
| Aged, 80 and over | 12 | 2025 | 2790 | 0.460 |
Why?
|
| Genome, Human | 2 | 2014 | 143 | 0.460 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 222 | 0.450 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 9 | 0.440 |
Why?
|
| Prostatic Neoplasms | 2 | 2023 | 1068 | 0.430 |
Why?
|
| Genetic Variation | 1 | 2017 | 429 | 0.420 |
Why?
|
| United States | 17 | 2025 | 5068 | 0.410 |
Why?
|
| Genetic Markers | 1 | 2014 | 146 | 0.400 |
Why?
|
| Incidence | 9 | 2025 | 1052 | 0.390 |
Why?
|
| Adenocarcinoma | 2 | 2014 | 287 | 0.380 |
Why?
|
| Chromosomes, Human, X | 1 | 2012 | 23 | 0.380 |
Why?
|
| Gene Amplification | 1 | 2012 | 23 | 0.380 |
Why?
|
| Comorbidity | 4 | 2023 | 723 | 0.370 |
Why?
|
| District of Columbia | 5 | 2021 | 73 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2024 | 727 | 0.350 |
Why?
|
| Butyrates | 1 | 2011 | 34 | 0.350 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 34 | 0.340 |
Why?
|
| CpG Islands | 3 | 2018 | 107 | 0.340 |
Why?
|
| Young Adult | 8 | 2025 | 4928 | 0.340 |
Why?
|
| Biological Products | 2 | 2023 | 91 | 0.340 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 100 | 0.340 |
Why?
|
| Gastrointestinal Tract | 1 | 2011 | 67 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 933 | 0.320 |
Why?
|
| Iran | 4 | 2017 | 199 | 0.320 |
Why?
|
| Age Factors | 7 | 2025 | 1135 | 0.310 |
Why?
|
| Vitamin D | 1 | 2011 | 196 | 0.310 |
Why?
|
| Infant | 3 | 2021 | 1142 | 0.300 |
Why?
|
| Lymphatic Metastasis | 2 | 2021 | 81 | 0.290 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2009 | 206 | 0.290 |
Why?
|
| Hepatitis C, Chronic | 2 | 2020 | 44 | 0.280 |
Why?
|
| Cohort Studies | 7 | 2025 | 1728 | 0.280 |
Why?
|
| Nuclear Proteins | 3 | 2009 | 330 | 0.280 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 437 | 0.270 |
Why?
|
| Odds Ratio | 5 | 2020 | 584 | 0.270 |
Why?
|
| Phylogeny | 4 | 2021 | 740 | 0.260 |
Why?
|
| Urban Health | 3 | 2015 | 99 | 0.250 |
Why?
|
| Child, Preschool | 2 | 2021 | 1515 | 0.250 |
Why?
|
| Toluene | 1 | 2006 | 11 | 0.250 |
Why?
|
| Chromium | 1 | 2006 | 29 | 0.250 |
Why?
|
| DNA Mismatch Repair | 2 | 2021 | 28 | 0.240 |
Why?
|
| Patient Compliance | 2 | 2019 | 225 | 0.240 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2025 | 8 | 0.230 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2024 | 184 | 0.220 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 637 | 0.220 |
Why?
|
| Minority Groups | 2 | 2023 | 663 | 0.220 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 274 | 0.220 |
Why?
|
| Aging | 2 | 2025 | 763 | 0.220 |
Why?
|
| Dextran Sulfate | 2 | 2021 | 17 | 0.220 |
Why?
|
| Adolescent | 5 | 2025 | 5949 | 0.220 |
Why?
|
| Age of Onset | 1 | 2024 | 114 | 0.220 |
Why?
|
| Diabetes Mellitus | 3 | 2021 | 531 | 0.220 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 557 | 0.210 |
Why?
|
| Genotype | 3 | 2024 | 792 | 0.210 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 310 | 0.210 |
Why?
|
| Crohn Disease | 2 | 2024 | 69 | 0.210 |
Why?
|
| Chi-Square Distribution | 5 | 2015 | 236 | 0.210 |
Why?
|
| Radioactive Waste | 1 | 2003 | 4 | 0.200 |
Why?
|
| Transcription Factors | 2 | 2020 | 722 | 0.200 |
Why?
|
| Life Style | 2 | 2017 | 326 | 0.200 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2014 | 15 | 0.200 |
Why?
|
| Logistic Models | 5 | 2020 | 1001 | 0.200 |
Why?
|
| Deoxyribonucleases | 2 | 2013 | 27 | 0.190 |
Why?
|
| Child | 2 | 2021 | 3381 | 0.190 |
Why?
|
| Computational Biology | 2 | 2017 | 324 | 0.190 |
Why?
|
| HCT116 Cells | 2 | 2021 | 40 | 0.190 |
Why?
|
| Metals | 1 | 2003 | 113 | 0.190 |
Why?
|
| Troponin | 1 | 2022 | 17 | 0.190 |
Why?
|
| Haplotypes | 2 | 2020 | 197 | 0.180 |
Why?
|
| Alleles | 2 | 2020 | 351 | 0.180 |
Why?
|
| ras Proteins | 2 | 2014 | 54 | 0.180 |
Why?
|
| Trans-Activators | 2 | 2020 | 190 | 0.180 |
Why?
|
| Prospective Studies | 5 | 2025 | 1570 | 0.180 |
Why?
|
| Africa | 1 | 2021 | 81 | 0.180 |
Why?
|
| Neoplasm Staging | 4 | 2016 | 366 | 0.170 |
Why?
|
| Cough | 1 | 2021 | 20 | 0.170 |
Why?
|
| Databases, Genetic | 2 | 2021 | 103 | 0.170 |
Why?
|
| Histones | 3 | 2013 | 194 | 0.170 |
Why?
|
| Latin America | 1 | 2020 | 53 | 0.170 |
Why?
|
| Early Detection of Cancer | 3 | 2020 | 428 | 0.170 |
Why?
|
| Mice | 6 | 2023 | 6490 | 0.170 |
Why?
|
| Occult Blood | 1 | 2020 | 32 | 0.170 |
Why?
|
| Inflammation | 3 | 2022 | 729 | 0.170 |
Why?
|
| Fever | 1 | 2021 | 62 | 0.170 |
Why?
|
| Anal Canal | 1 | 2020 | 32 | 0.160 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 175 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 284 | 0.160 |
Why?
|
| beta Catenin | 1 | 2020 | 75 | 0.160 |
Why?
|
| Colitis, Ulcerative | 1 | 2020 | 68 | 0.150 |
Why?
|
| Colon, Ascending | 1 | 2019 | 3 | 0.150 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 4 | 0.150 |
Why?
|
| Colon, Transverse | 1 | 2019 | 5 | 0.150 |
Why?
|
| Quality of Health Care | 1 | 2020 | 158 | 0.150 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 436 | 0.150 |
Why?
|
| Rectum | 1 | 2019 | 27 | 0.150 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 101 | 0.150 |
Why?
|
| Diet | 2 | 2023 | 810 | 0.150 |
Why?
|
| DNA, Viral | 1 | 2020 | 323 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 158 | 0.150 |
Why?
|
| Cell Movement | 2 | 2020 | 640 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 236 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2024 | 501 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 211 | 0.140 |
Why?
|
| Animals | 8 | 2024 | 16694 | 0.140 |
Why?
|
| Feasibility Studies | 1 | 2019 | 238 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2020 | 189 | 0.140 |
Why?
|
| Sex Factors | 5 | 2025 | 1004 | 0.140 |
Why?
|
| Infant, Newborn | 1 | 2021 | 960 | 0.140 |
Why?
|
| Digestive System Neoplasms | 1 | 2017 | 4 | 0.140 |
Why?
|
| Mass Screening | 2 | 2019 | 531 | 0.140 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 928 | 0.130 |
Why?
|
| Hepacivirus | 1 | 2017 | 73 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 1679 | 0.130 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 64 | 0.130 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 74 | 0.130 |
Why?
|
| Fatty Liver | 1 | 2017 | 71 | 0.130 |
Why?
|
| Time Factors | 3 | 2017 | 1845 | 0.130 |
Why?
|
| Biopsy | 2 | 2014 | 176 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2014 | 55 | 0.120 |
Why?
|
| Cell Proliferation | 2 | 2020 | 1420 | 0.120 |
Why?
|
| Pancreatic Cyst | 1 | 2016 | 6 | 0.120 |
Why?
|
| Microarray Analysis | 2 | 2014 | 64 | 0.120 |
Why?
|
| Pathology, Clinical | 1 | 2015 | 4 | 0.120 |
Why?
|
| Demography | 2 | 2016 | 195 | 0.120 |
Why?
|
| Lymph Node Excision | 1 | 2015 | 26 | 0.120 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2013 | 78 | 0.120 |
Why?
|
| Diverticulosis, Colonic | 1 | 2015 | 2 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2014 | 574 | 0.110 |
Why?
|
| Apoptosis | 2 | 2013 | 1541 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 224 | 0.110 |
Why?
|
| Endoscopy | 1 | 2014 | 15 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 37 | 0.110 |
Why?
|
| Mercury | 2 | 2006 | 39 | 0.110 |
Why?
|
| Appointments and Schedules | 1 | 2014 | 27 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2020 | 915 | 0.110 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 22 | 0.110 |
Why?
|
| Obesity | 3 | 2021 | 1129 | 0.110 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 7 | 0.110 |
Why?
|
| Phenotype | 1 | 2017 | 774 | 0.100 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 121 | 0.100 |
Why?
|
| Gene Dosage | 1 | 2014 | 75 | 0.100 |
Why?
|
| Metagenomics | 1 | 2013 | 43 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2013 | 61 | 0.100 |
Why?
|
| DNA Helicases | 1 | 2013 | 46 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 118 | 0.100 |
Why?
|
| Oxidation-Reduction | 2 | 2006 | 448 | 0.100 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 2598 | 0.100 |
Why?
|
| Genomic Instability | 1 | 2013 | 36 | 0.100 |
Why?
|
| Endodeoxyribonucleases | 1 | 2012 | 29 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2012 | 5 | 0.100 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 14 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2012 | 95 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 37 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2014 | 2111 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 979 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2012 | 108 | 0.090 |
Why?
|
| Oman | 2 | 2008 | 7 | 0.090 |
Why?
|
| Administration, Oral | 2 | 2023 | 256 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 150 | 0.090 |
Why?
|
| MutS Homolog 2 Protein | 3 | 2024 | 32 | 0.090 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2011 | 11 | 0.090 |
Why?
|
| Overweight | 1 | 2014 | 248 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 382 | 0.090 |
Why?
|
| Seasons | 1 | 2011 | 133 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 165 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2012 | 383 | 0.080 |
Why?
|
| Puerto Rico | 2 | 2025 | 1376 | 0.080 |
Why?
|
| Chromosomal Instability | 1 | 2010 | 20 | 0.080 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2010 | 71 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2011 | 137 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2010 | 37 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 1804 | 0.080 |
Why?
|
| Disease Progression | 3 | 2023 | 660 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2011 | 253 | 0.080 |
Why?
|
| Proteins | 1 | 2012 | 383 | 0.070 |
Why?
|
| Cytokines | 2 | 2024 | 661 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2013 | 426 | 0.070 |
Why?
|
| Proteomics | 1 | 2011 | 363 | 0.070 |
Why?
|
| Oxidative Stress | 2 | 2024 | 990 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 61 | 0.070 |
Why?
|
| Janus Kinase 2 | 1 | 2008 | 33 | 0.070 |
Why?
|
| Genetics, Population | 1 | 2008 | 118 | 0.070 |
Why?
|
| STAT5 Transcription Factor | 1 | 2008 | 48 | 0.070 |
Why?
|
| Mesoderm | 1 | 2008 | 73 | 0.070 |
Why?
|
| Body Weight | 2 | 2021 | 428 | 0.070 |
Why?
|
| Azacitidine | 2 | 2020 | 22 | 0.070 |
Why?
|
| Gene Silencing | 2 | 2021 | 154 | 0.070 |
Why?
|
| Outpatients | 2 | 2019 | 34 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2013 | 641 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 3073 | 0.060 |
Why?
|
| Intestinal Mucosa | 2 | 2021 | 131 | 0.060 |
Why?
|
| Geologic Sediments | 1 | 2006 | 47 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 96 | 0.060 |
Why?
|
| Survival Rate | 2 | 2020 | 353 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 1554 | 0.060 |
Why?
|
| Shewanella | 1 | 2005 | 5 | 0.060 |
Why?
|
| Independent Living | 1 | 2025 | 47 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 602 | 0.060 |
Why?
|
| Propensity Score | 1 | 2024 | 58 | 0.050 |
Why?
|
| Tissue Array Analysis | 2 | 2016 | 79 | 0.050 |
Why?
|
| Bacterial Proteins | 2 | 2006 | 580 | 0.050 |
Why?
|
| Water Pollutants, Chemical | 1 | 2006 | 170 | 0.050 |
Why?
|
| Histocompatibility Antigens | 1 | 2023 | 12 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2024 | 60 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2024 | 78 | 0.050 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2023 | 30 | 0.050 |
Why?
|
| Genetic Engineering | 1 | 2003 | 36 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 61 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2003 | 82 | 0.050 |
Why?
|
| Virulence | 1 | 2024 | 238 | 0.050 |
Why?
|
| Escherichia coli | 1 | 2006 | 461 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2013 | 113 | 0.050 |
Why?
|
| Prostate | 1 | 2023 | 152 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 97 | 0.050 |
Why?
|
| Histone Code | 1 | 2022 | 13 | 0.050 |
Why?
|
| Sirtuin 1 | 1 | 2022 | 33 | 0.050 |
Why?
|
| Temperature | 1 | 2003 | 314 | 0.050 |
Why?
|
| Retroelements | 1 | 2021 | 14 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2023 | 379 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1019 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2021 | 75 | 0.040 |
Why?
|
| Antioxidants | 1 | 2024 | 439 | 0.040 |
Why?
|
| Serotonin | 1 | 2021 | 125 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2020 | 19 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2020 | 152 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2020 | 26 | 0.040 |
Why?
|
| Interferons | 1 | 2020 | 37 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 286 | 0.040 |
Why?
|
| Quality of Life | 1 | 2025 | 598 | 0.040 |
Why?
|
| Cathartics | 1 | 2019 | 6 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2021 | 452 | 0.040 |
Why?
|
| DNA | 1 | 2022 | 594 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 201 | 0.040 |
Why?
|
| Perception | 1 | 2020 | 209 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 506 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2019 | 101 | 0.040 |
Why?
|
| Ambulatory Care | 1 | 2019 | 81 | 0.040 |
Why?
|
| Viral Load | 1 | 2020 | 344 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 309 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 704 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2017 | 8 | 0.030 |
Why?
|
| Colombia | 1 | 2017 | 30 | 0.030 |
Why?
|
| Cell Survival | 1 | 2020 | 934 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2017 | 224 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1582 | 0.030 |
Why?
|
| Colonoscopes | 1 | 2016 | 2 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2016 | 95 | 0.030 |
Why?
|
| Genetic Loci | 1 | 2017 | 102 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2016 | 39 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 157 | 0.030 |
Why?
|
| SEER Program | 1 | 2016 | 157 | 0.030 |
Why?
|
| Hypertension | 1 | 2021 | 817 | 0.030 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 34 | 0.030 |
Why?
|
| Hospitals | 1 | 2014 | 115 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 44 | 0.030 |
Why?
|
| Age Distribution | 1 | 2013 | 249 | 0.020 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 2012 | 1 | 0.020 |
Why?
|
| Serine Proteases | 1 | 2012 | 4 | 0.020 |
Why?
|
| Cysteine Proteases | 1 | 2012 | 3 | 0.020 |
Why?
|
| Etoposide | 1 | 2012 | 21 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2012 | 9 | 0.020 |
Why?
|
| Base Pairing | 1 | 2012 | 41 | 0.020 |
Why?
|
| Nucleosomes | 1 | 2012 | 31 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2013 | 162 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2012 | 53 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2012 | 3 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 21 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 295 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1265 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 160 | 0.020 |
Why?
|
| DNA Damage | 1 | 2013 | 358 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2013 | 358 | 0.020 |
Why?
|
| Motor Activity | 1 | 2013 | 438 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1221 | 0.020 |
Why?
|
| Calcium | 1 | 2012 | 487 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 884 | 0.020 |
Why?
|
| Genes, p16 | 1 | 2009 | 11 | 0.020 |
Why?
|
| Genes, APC | 1 | 2009 | 15 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 108 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 1051 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2013 | 585 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 96 | 0.020 |
Why?
|
| Mucins | 1 | 2008 | 69 | 0.020 |
Why?
|
| Culture Media | 1 | 2006 | 96 | 0.010 |
Why?
|
| Cadmium | 1 | 2006 | 54 | 0.010 |
Why?
|
| Cytosol | 1 | 2006 | 98 | 0.010 |
Why?
|
| Radiation, Ionizing | 1 | 2005 | 13 | 0.010 |
Why?
|
| Radiation Tolerance | 1 | 2005 | 12 | 0.010 |
Why?
|
| Zinc | 1 | 2006 | 130 | 0.010 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2006 | 168 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 118 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 633 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2006 | 133 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 670 | 0.010 |
Why?
|
| Manganese | 1 | 2005 | 89 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2006 | 400 | 0.010 |
Why?
|
| Iron | 1 | 2005 | 247 | 0.010 |
Why?
|
| HIV Infections | 1 | 2017 | 2535 | 0.010 |
Why?
|